title: [Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].
abstract: BACKGROUND
  Low-grade gliomas represent a heterogeneous group of primary brain malignancies. The current diagnostics of these tumors rely strongly on histological classification. With the development of molecular cytogenetic methods several genetic markers were described, contributing to a better distinction of glial subtypes. The aim of this study was to assess the frequency of acquired chromosomal aberrations in lowgrade gliomas and to search for new genomic changes associated with higher risk of tumor progression.
  
  
  METHODS
  We analysed biopsy specimens from 41 patients with histological dia-gnosis of low-grade glioma using interphase fluorescence in situ hybridization (I FISH) and single nucleotide polymorphism (SNP) array techniques (19 females and 22 males, medium age 42 years).
  
  
  RESULTS
  Besides notorious and most frequent finding of combined deletion of 1p/ 19q (81.25% patients) several other recurrent aberrations were described in patients with oligodendrogliomas: deletions of p and q arms of chromosome 4 (25% patients), deletions of the short arms of chromosome 9 (18.75% patients), deletions of the long arms of chromosome 13 and monosomy of chromosome 18 (18.75% patients). In bio-psy specimens from patients with astrocytomas, we often observed deletion of 1p (24% patients), amplification of the long arms of chromosome 7 (16% patients), deletion of the long arm of chromosome 13 (20% patients), segmental uniparental disomy (UPD) of the short arms of chromosome 17 (60% patients) and deletion of the long arms of chromosome 19 (28% patients). In one patient we detected a shuttered chromosome 10 resulting from chromothripsis.
  
  
  CONCLUSIONS
  Using a combination of I FISH and SNP array, we detected not only known chromosomal changes but also new or less frequent recur-rent aberrations. Their role in cancer  cell progression and their impact on low grade gliomas classification remains to be elucidated in a larger cohort of patients.
authors.forename: H
authors.initials: H
authors.lastname: Lhotská
authors.forename: Z
authors.initials: Z
authors.lastname: Zemanová
authors.forename: F
authors.initials: F
authors.lastname: Kramář
authors.forename: L
authors.initials: L
authors.lastname: Lizcová
authors.forename: K
authors.initials: K
authors.lastname: Svobodová
authors.forename: S
authors.initials: S
authors.lastname: Ransdorfová
authors.forename: D
authors.initials: D
authors.lastname: Bystřická
authors.forename: Z
authors.initials: Z
authors.lastname: Krejčík
authors.forename: P
authors.initials: P
authors.lastname: Hrabal
authors.forename: A
authors.initials: A
authors.lastname: Dohnalová
authors.forename: M
authors.initials: M
authors.lastname: Kaiser
authors.forename: K
authors.initials: K
authors.lastname: Michalová
mesh_terms: D000328:Adult; D001254:Astrocytoma / Q000235:genetics / Q000473:pathology; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology; D002869:Chromosome Aberrations; D005260:Female; D017353:Gene Deletion; D005910:Glioma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008875:Middle Aged; D009837:Oligodendroglioma / Q000235:genetics / Q000473:pathology